{"date":"2026-06-29","count":42,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6827-2026-06-29-2310-1gb914h","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-29","time":"23:10:25","subject":"公告本公司MPB-1523 MRI顯影劑-肝細胞癌接獲中國CDE溝通交流會議記錄","clause":"第8款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2026-06-29 23:10，「公告本公司MPB-1523 MRI顯影劑-肝細胞癌接獲中國CDE溝通交流會議記錄」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2026-06-29-2122-zhkfod","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-29","time":"21:22:51","subject":"公告本公司115年股東常會全面改選董事當選名單","clause":"第6款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2026-06-29 21:22，「公告本公司115年股東常會全面改選董事當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2026-06-29-2120-1r3k9cn","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-29","time":"21:20:59","subject":"公告本公司115年股東常會決議通過解除新任董事及其代表人競業禁止之限制","clause":"第22款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2026-06-29 21:20，「公告本公司115年股東常會決議通過解除新任董事及其代表人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2026-06-29-2118-404p2v","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-29","time":"21:18:27","subject":"公告本公司第二屆審計委員會委員","clause":"第6款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2026-06-29 21:18，「公告本公司第二屆審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2026-06-29-2117-9769qc","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-29","time":"21:17:22","subject":"公告本公司董事會選任董事長","clause":"第6款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2026-06-29 21:17，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2026-06-29-2116-1jb8ii5","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-29","time":"21:16:04","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2026-06-29 21:16，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2026-06-29-2025-16jsfd1","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2026-06-29","time":"20:25:38","subject":"公告本公司115年現金增資股款催繳事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2026-06-29 20:25，「公告本公司115年現金增資股款催繳事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2026-06-29-2025-11lbsft","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2026-06-29","time":"20:25:07","subject":"公告本公司115年現金增資全體董事放棄認購股數達得認購股數二分之一以上，並洽特定人認購事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2026-06-29 20:25，「公告本公司115年現金增資全體董事放棄認購股數達得認購股數二分之一以上，並洽特定人認購事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2026-06-29-1835-sta7c0","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2026-06-29","time":"18:35:19","subject":"本公司董事會通過與日本指標性藥廠簽訂HER2生物相似藥EG1206A日本地區之授權銷售合約","clause":"第10款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2026-06-29 18:35，「本公司董事會通過與日本指標性藥廠簽訂HER2生物相似藥EG1206A日本地區之授權銷售合約」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6847-2026-06-29-1815-u1t031","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2026-06-29","time":"18:15:48","subject":"本公司董事會推選董事長","clause":"第6款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2026-06-29 18:15，「本公司董事會推選董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6847-2026-06-29-1814-1qo1onv","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2026-06-29","time":"18:14:56","subject":"公告本公司薪酬委員會委員任期屆滿","clause":"第6款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2026-06-29 18:14，「公告本公司薪酬委員會委員任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6847-2026-06-29-1814-r8x24z","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2026-06-29","time":"18:14:06","subject":"公告本公司審計委員會委員任期屆滿改選","clause":"第6款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2026-06-29 18:14，「公告本公司審計委員會委員任期屆滿改選」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6847-2026-06-29-1813-otyk02","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2026-06-29","time":"18:13:38","subject":"本公司115年股東常會決議解除新任董事競業禁止之限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2026-06-29 18:13，「本公司115年股東常會決議解除新任董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6847-2026-06-29-1813-qhpe8r","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2026-06-29","time":"18:13:14","subject":"公告本公司115年股東常會全面改選董事及獨立董事案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2026-06-29 18:13，「公告本公司115年股東常會全面改選董事及獨立董事案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6847-2026-06-29-1812-ds864w","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2026-06-29","time":"18:12:57","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2026-06-29 18:12，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2026-06-29-1759-10ik2gj","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-06-29","time":"17:59:14","subject":"代重要子公司育禾管理顧問股份有限公司公告臺灣新竹地方法院114年度重訴字第210號訴訟判決主文","clause":"第2款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2026-06-29 17:59，「代重要子公司育禾管理顧問股份有限公司公告臺灣新竹地方法院114年度重訴字第210號訴訟判決主文」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4728-2026-06-29-1758-9o00en","company_id":"4728","company":"雙美","market":"上櫃","industry":"生技醫療","date":"2026-06-29","time":"17:58:53","subject":"公告本公司法人董事改派法人代表人。","clause":"第6款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：雙美（4728），2026-06-29 17:58，「公告本公司法人董事改派法人代表人。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2026-06-29-1758-13sk2v0","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-29","time":"17:58:36","subject":"公告本公司審計委員會委員異動","clause":"第6款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2026-06-29 17:58，「公告本公司審計委員會委員異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2026-06-29-1757-pii1n3","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-29","time":"17:57:48","subject":"公告本公司115年股東常會補選獨立董事當選名單","clause":"第6款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2026-06-29 17:57，「公告本公司115年股東常會補選獨立董事當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2026-06-29-1756-1jb8ii5","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-29","time":"17:56:46","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2026-06-29 17:56，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4163-2026-06-29-1711-v9fe7m","company_id":"4163","company":"鐿鈦","market":"上櫃","industry":"生技醫療","date":"2026-06-29","time":"17:11:57","subject":"公告本公司董事會決議選任董事長","clause":"第6款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：鐿鈦（4163），2026-06-29 17:11，「公告本公司董事會決議選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6572-2026-06-29-1638-jflio5","company_id":"6572","company":"博錸","market":"興櫃","industry":"生技醫療","date":"2026-06-29","time":"16:38:16","subject":"公告本公司115年股東會重要決議事項","clause":"第15款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：博錸（6572），2026-06-29 16:38，「公告本公司115年股東會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2026-06-29-1637-7rzr08","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2026-06-29","time":"16:37:08","subject":"公告本公司法人董事指派代表人","clause":"第6款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2026-06-29 16:37，「公告本公司法人董事指派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2026-06-29-1636-u76c2w","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2026-06-29","time":"16:36:19","subject":"公告本公司董事會通過委任第三屆審計委員會委員","clause":"第6款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2026-06-29 16:36，「公告本公司董事會通過委任第三屆審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2026-06-29-1635-1e7iplt","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2026-06-29","time":"16:35:23","subject":"公告本公司董事會通過委任第六屆薪資報酬委員會委員","clause":"第6款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2026-06-29 16:35，「公告本公司董事會通過委任第六屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2026-06-29-1634-1ybu2wd","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2026-06-29","time":"16:34:33","subject":"公告本公司董事會推舉韓開程先生續任董事長","clause":"第6款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2026-06-29 16:34，「公告本公司董事會推舉韓開程先生續任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2026-06-29-1633-1fb6d2n","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2026-06-29","time":"16:33:32","subject":"公告本公司115年股東常會決議通過解除新任董事競業禁止限制","clause":"第21款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2026-06-29 16:33，「公告本公司115年股東常會決議通過解除新任董事競業禁止限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2026-06-29-1632-1bzc9ms","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2026-06-29","time":"16:32:39","subject":"公告本公司115年股東常會改選董事(含獨立董事3人)","clause":"第6款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2026-06-29 16:32，「公告本公司115年股東常會改選董事(含獨立董事3人)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2026-06-29-1627-1jb8ii5","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2026-06-29","time":"16:27:29","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2026-06-29 16:27，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4115-2026-06-29-1625-112etxd","company_id":"4115","company":"善德生技","market":"興櫃","industry":"生技醫療","date":"2026-06-29","time":"16:25:51","subject":"公告本公司董事會決議通過委任第四屆薪資報酬委員會委員。","clause":"第6款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：善德生技（4115），2026-06-29 16:25，「公告本公司董事會決議通過委任第四屆薪資報酬委員會委員。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4115-2026-06-29-1625-1udd9xf","company_id":"4115","company":"善德生技","market":"興櫃","industry":"生技醫療","date":"2026-06-29","time":"16:25:09","subject":"公告本公司新任法人董事指派代表人","clause":"第6款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：善德生技（4115），2026-06-29 16:25，「公告本公司新任法人董事指派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4115-2026-06-29-1624-peusgi","company_id":"4115","company":"善德生技","market":"興櫃","industry":"生技醫療","date":"2026-06-29","time":"16:24:17","subject":"公告本公司第四屆審計委員會委員","clause":"第6款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：善德生技（4115），2026-06-29 16:24，「公告本公司第四屆審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4115-2026-06-29-1623-j7v8s1","company_id":"4115","company":"善德生技","market":"興櫃","industry":"生技醫療","date":"2026-06-29","time":"16:23:21","subject":"公告本公司董事會決議推選董事長","clause":"第6款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：善德生技（4115），2026-06-29 16:23，「公告本公司董事會決議推選董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4115-2026-06-29-1622-cr5gmb","company_id":"4115","company":"善德生技","market":"興櫃","industry":"生技醫療","date":"2026-06-29","time":"16:22:35","subject":"公告本公司115年股東常會決議解除董事競業禁止之限制","clause":"第22款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：善德生技（4115），2026-06-29 16:22，「公告本公司115年股東常會決議解除董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4771-2026-06-29-1622-1de765s","company_id":"4771","company":"望隼","market":"上市","industry":"生技醫療","date":"2026-06-29","time":"16:22:26","subject":"公告本公司115年現金股利除息基準日及發放日","clause":"第14款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：望隼（4771），2026-06-29 16:22，「公告本公司115年現金股利除息基準日及發放日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4115-2026-06-29-1621-1rayw5g","company_id":"4115","company":"善德生技","market":"興櫃","industry":"生技醫療","date":"2026-06-29","time":"16:21:37","subject":"公告本公司115年股東常會全面改選董事(含獨立董事)當選名單","clause":"第6款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：善德生技（4115），2026-06-29 16:21，「公告本公司115年股東常會全面改選董事(含獨立董事)當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4115-2026-06-29-1620-1jb8ii5","company_id":"4115","company":"善德生技","market":"興櫃","industry":"生技醫療","date":"2026-06-29","time":"16:20:38","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：善德生技（4115），2026-06-29 16:20，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-06-29-1614-a5ie9t","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-06-29","time":"16:14:34","subject":"公告本公司受邀參加群益金鼎證券舉辦之再生醫療與消費醫療產業論壇","clause":"第12款","fact_date":"2026-07-01","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-06-29 16:14，「公告本公司受邀參加群益金鼎證券舉辦之再生醫療與消費醫療產業論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6796-2026-06-29-1532-s364tb","company_id":"6796","company":"晉弘","market":"上市","industry":"生技醫療","date":"2026-06-29","time":"15:32:05","subject":"公告本公司訂定除息基準日","clause":"第14款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：晉弘（6796），2026-06-29 15:32，「公告本公司訂定除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2026-06-29-1429-1fs2lsu","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2026-06-29","time":"14:29:52","subject":"公告本公司115年5月份自結合併財務報告之負債比率、流動比率及速動比率","clause":"第53款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2026-06-29 14:29，「公告本公司115年5月份自結合併財務報告之負債比率、流動比率及速動比率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3176-2026-06-29-1419-s6exdr","company_id":"3176","company":"基亞","market":"上櫃","industry":"生技醫療","date":"2026-06-29","time":"14:19:59","subject":"基亞異體自然殺手細胞(Magicell-NK)第一/二期人體臨床試驗收錄第一位受試者","clause":"第10款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：基亞（3176），2026-06-29 14:19，「基亞異體自然殺手細胞(Magicell-NK)第一/二期人體臨床試驗收錄第一位受試者」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3164-2026-06-29-1053-lvmhu7","company_id":"3164","company":"景岳","market":"上市","industry":"生技醫療","date":"2026-06-29","time":"10:53:46","subject":"公告本公司第五屆薪資報酬委員會委員任期屆滿","clause":"第6款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：景岳（3164），2026-06-29 10:53，「公告本公司第五屆薪資報酬委員會委員任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}